$98.05
-1.47-1.48%
At close: -
$98.99
0.940.96%
After Hours: Dec 20, 7:59 PM EDT
Comments
Loading...
Latest news for Merck & Co (NYSE:MRK) Stock
Merck & Co Stock (NYSE: MRK)
Categories: All
Friday, December 20, 2024
Thursday, December 19, 2024
- Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
- Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
- Stock Of The Day: Where Does The Merck Downtrend End?
- Merck Agrees To Purchase $50M Of Personalis C...
- Merck Announced Topline Results From Two Phas...
Wednesday, December 18, 2024
- Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
- What's Going On With Viking Therapeutics Stock On Wednesday?
- 10 Health Care Stocks With Whale Alerts In Today's Session
- What's Going On With Merck Shares Wednesday?
- Merck, Hansoh Pharma Enter Exclusive Global L...
Tuesday, December 17, 2024
Monday, December 16, 2024
Friday, December 13, 2024
Wednesday, December 11, 2024
Tuesday, December 10, 2024
Monday, December 09, 2024
Sunday, December 08, 2024
Thursday, December 05, 2024
Tuesday, December 03, 2024
Monday, December 02, 2024
Monday, November 25, 2024
Friday, November 22, 2024
Thursday, November 21, 2024
Wednesday, November 20, 2024
Tuesday, November 19, 2024
- Watching Incyte; Sky News City Editor Mark Kl...
- Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
- Merck Increases Quarterly Dividend From $0.77...
- Merck shares are trading higher after the com...
- Merck Reports Topline Results From Pivotal Ph...